AzTrials
AzTrials

Major DepressionDepressionNCT04489485

Online System for Identifying and Addressing Teen Depression in Primary Care

An observational study of Major Depression and Dysthymia, run by Total Child Health, Inc. at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A novel web-based module (Teen Depression Module or TDM)has been created for assisting primary care providers (PCPs) in screening for and addressing and referring teens with depression. Read more about this study

Who is it for?
Ages 12 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Major Depression, Dysthymia, Depressive Symptoms
What is being tested?
Teen Depression Module used for care
How many people
580 participants
Where
1 siteUnited States
Study dates
1 Feb 2021to Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: All teens coming to participating PCPs for well child visits during the study period and their adult caregivers for those under 18

Who may be able to join

  • English speaking teens
  • English speaking caregivers

Who cannot join

  • Non English speaking teens
  • Non English speaking caregivers

Trial locations and contacts

1 site in 1 country.

Barbara Howard, MD contact

4436189104

bhoward@chadis.com

Kerry A Bet, MPH contact

8884242347

kbet@chadis.com

United States1 site, 1 recruiting
  • Total Child Health

    Baltimore, Maryland, 21210

    Barbara J Howard, MD, 443-618-9104, bhoward@chadis.com

    Kerry A Bet, MPH, 8884242347, kbet@chadis.com

    Recruiting

Other trials in United States

About this study

A novel web-based module (Teen Depression Module or TDM)has been created for assisting primary care providers (PCPs) in screening for and addressing and referring teens with depression. This is a cluster randomized Quality Improvement study to determine if use of the TDM that includes collecting information on strengths and goals as part of well child care will improve detection of depression, referral success, and teen's use of alternative helping strategies with resulting improvement in depression symptoms.

Read the detailed description

Phase II Summary for finalizing and testing the CHADIS Teen Depression Module (TDM) These aims are unchanged except that health screening visits may be in-person or conducted via telehealth.

II-1. Revise programming and training materials: TDM- an addition for primary care screening and care for teen depression as part of the Comprehensive Health and Decision Information System (CHADIS) online questionnaire delivery system with decision support including "motivational interviewing teleprompters", care coordination functionality for referrals, and text chats- will be revised and programmed as needed to adjust for Phase 1 feedback and training materials created.

II-2 Recruit 20 study PCP's, set up care coordination with MH specialists and assess: Investigators will recruit 20 primary care providers (PCPs), assuring representative Medicaid-insured teens, and randomize to intervention or control. Intervention PCPs will identify their local Mental Health (MH) resources to recruit for referrals and use of care coordination functionality. 2 Therapists, 2 PCPs, and 2 Psychiatrists (Psy) using the care coordination will give feedback on functionality, acceptability and likelihood of continued use as well as use of a text messaging robot messaging about referrals after the baseline. Investigators will document current PCP access to MH services.

II-3 Baseline (3 mo.), refine implementation strategies using QI Maintenance of Certification (MOC-4) sessions:

All 20 PCPs will use the Patient Health Questionnaire-9 (PHQ-9) for depression (without follow-up questions) for a baseline, and have implementation issues addressed using Quality Improvement (QI) methods. Data will be collected from teens and parents before in person or telehealth Health Supervision Visits (HSV) using CHADIS. Data on rates of depression screening using CHADIS and billing data will be shared with PCPs as part of Maintenance of Certification Part 4 (MOC-4) sessions for intervention and controls. Teens (<=480) will be sent a text survey post visit of any strength- or emotion- supporting care received.

II-4 Create child psychiatry version of TDM: Denver team will modify TDM for Psy including care plans.

II-5 Obtain MOC-4 approval for child psychiatry by American Board of Medical Specialties (covering American Board of Psychiatry and Neurology) for Child Psychiatrists for use of the TDM created in II-4 and MOC-4 will be offered to participating Child Psychiatrists.

II-6 Intervention trial: (See Figure) Primary Question 1 (PQ1). For teens PHQ positive, does TDM use result in lower Short Mood \& Feelings Questionnaire (SMFQ) scores at 3-, 6-and 11.5-months vs at start of intervention? Primary Question 2. For teens PHQ positive, does TDM use result in lower teen and parent SMFQ scores at 3-, 6-and 11.5-months vs controls? Secondary Question 1 (SQ1): Of teens PHQ positive, does TDM use result in higher rates of accessing treatment at 3-, 6-and 11.5 months vs controls? Secondary Question 2. Does QI method increase rates of teens screened? Secondary Question 3. Does QI method increase rates of Ask Suicide Questions (ASQ) screening? Design: A cluster randomized trial with a 2-group pretest-posttest design clustered at the PCP level will determine pre-post differences within patients and intervention vs control group differences.

Sample size estimates consider the design effect and use an Intent to Treat model. Sample sizes of 107/PCP in both intervention and control will achieve 89.5% power to detect a difference between group means of >=2; also sufficient power for Secondary Questions 1-3. Procedure: Both groups: All teens before HSV will do: Visit Priorities, Teen Health \& Goals comprehensive of standard guidelines, and PHQ-9 with follow up to SMFQ, if positive and get health information chats with links to education/advice in their CHADIS Care Portal. All parents will do Visit Priorities and Pediatric Symptom Checklist-17 (PSC) for behavior/mood with follow-up parent SMFQ if the internalizing subscale is positive and can access "handouts" in the parent Care Portal. All PCPs see questionnaire results and earn MOC-4. Intervention group: Teens: will do: goals/strengths/values and ASQ. If PHQ-9 is >=8 they will get follow-up questions and SMFQ. Teens will get follow-up text message robot dialogues with topic based on if a referral was accepted and other priorities. Chats may encourage strengths and provide resources, goals, mindfulness apps, journaling or depression-Cognitive Behavior Therapy dialogues for PHQ positive teens. Parents: get resources. PCPs: will use TDM results and decision support to detect, educate on depression, and motivate for intervention. They earn MOC.

Follow Up Measures: All teens and parents: get email/text reminders to do questionnaires 3, 6 and 11.5 months (pre next HSV) after initial HSV. Teens positive on initial PHQ-9 in both groups will be paid (and called) to do a repeat PHQ-9 with follow-up about interval treatment and parents will do SMFQ and provide impressions of PCP management and success of any referrals. Rates for Ask Suicide Screening Questions (ASSQ) will be in the intervention group only, as it is not usual care, but any PCP may use it. Evaluation will include: depression screening rates, decision support use, proportions of positive teens referred via care coordination and teen use of resources.

II.7 Analysis of Results of Intervention: Initial: Descriptive analyses. Primary Questions 1\&2: t-tests adjusted for design effect, categorical statistical tests of inference appropriately matched to the underlying distributions of the measures used at T1 and T2, adjusted for design. Secondary Question 2: Chi-Squared Test of Independence on two cross-sectional samples tabulated at T0 and T1. Rates of ASQ use will be assessed for T2-T3. Tests will be applied to 2 cross-sectional samples regardless of treatment arm. Multi-Level Linear Regression models for Primary Questions 1-2 and Logistic Regression models for Secondary Questions 1-3 will assess impact of patient characteristics and item responses, and control for design effect of a cluster-randomized design.

Being tested
Teen Depression Module used for care
Keywords
depression
Medical subject headings
Depressive Disorder, Major, Dysthymic Disorder, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Teen Depression Module used for careBehavioural

    All teens coming for routine well child care to the enhanced group PCPs will have depression screening with strengths and goals and a depression screen with follow up suggestions for activities to help any depression symptoms, and treatment using the Teen Depression Module and offered a depression chabot. Suicide screening will be conducted.

Study groups in NCT04489485
Study groupRoleWhat they receive
Primary Care Providers (PCP)20 PCP who provide well child care to teens 12-18. After randomization, 10 PCPs in the enhanced care group will use the Teen Depression Module for care.
Receives: Behavioral: Teen Depression Module used for care
Standard care teensAll teens coming for routine well child care to the control group PCPs will have routine depression screening and Youth Health Questionnaire without goals to inform treatment as usual. They will be offered a goals text messaging conversation. Suicide screening will be at the discretion of the PCP.
Enhanced care teensAll teens coming for routine well child care to the enhanced group PCPs will have depression screening with strengths and goals and a depression screen with follow up suggestions for activities to help any depression symptoms, as well as Youth Health Questionnaire with goals and then they will receive treatment guided by the Teen Depression Module and offered a depression text messaging conversation. Suicide screening will be conducted.
Receives: Behavioral: Teen Depression Module used for care
Standard care- caregiversAll caregivers of teens <18 years old coming for routine well child care to the control group PCPs will complete a Pediatric Symptom Checklist and Short Moods and Feelings Questionnaire, plus a Youth Health Questionnaire- Parent version to inform treatment as usual. If the internalizing subscale is positive the caregiver will also complete the Short Moods and Feelings Questionnaire and 3, 6 and 11.5 month follow up report of Intervention received (Parent Intervention Questionnaire)
Enhanced care- caregiversAll caregivers of teens <18 years old coming for routine well child care to the enhanced group PCPs will complete a Pediatric Symptom Checklist plus a Youth Health Questionnaire- Parent version to inform treatment as usual. If the internalizing subscale is positive the caregiver will also complete the Short Moods and Feelings Questionnaire and 3, 6 and 11.5 month follow up report of Intervention received (Parent Intervention Questionnaire)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Short Moods and Feelings Questionnaire

    A brief screen of depressed mood completed by teen, 0-26 with 26 worst

    Measured: Day 1 well visit, day 1 + 3 months, day 1 + 6 months, and day 1 + 11.5 months

  2. Change in Short Moods and Feelings Questionnaire- Parent version

    A brief screen of depressed mood completed by parent, 0-26 with 26 worst

    Measured: Day 1 well visit, day 1 + 3 months, day 1 + 6 months, and day 1 + 11.5 months

Secondary outcomes (3)
  1. Change in Self report of treatment access

    Teen report of depression treatment access, accessed or not accessed with accessed considered better

    Measured: Day 1 well visit when there is a positive depression screen, day 1 + 3 months, day 1 + 6 months, and day 1 + 11.5 months

  2. Patient Health Questionnaire-9 (PHQ-9)

    Numbers of teens screened with PHQ-9 for depression. This outcome is not the score of the tool but numbers completing the tool with range 0-2600 with higher better.

    Measured: Entire study period of up to 3 years

  3. Ask Suicide Screening Questions (ASSQ)

    Numbers of teens screened with ASSQ for suicidal ideation, scores 0-8 with higher worst. This Outcome is number screened with range 0-2600 with higher better.

    Measured: Entire study period of up to 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2020
  2. Study start1 Feb 2021
  3. Primary completionJun 2023 (estimated)
  4. Study completionJun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
580 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04489485
Sponsor's protocol ID
R44MH116751
Other IDs
1R44MH116751-01A1
Acronym
Depression
Status last verified
Mar 2022
First submitted
19 Jun 2020
Last updated
22 Mar 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: After publication of results de-identified data may be available to qualified researchers.

Questions about this trial

What is this clinical trial studying?

An observational study of Major Depression and Dysthymia, run by Total Child Health, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Barbara Howard, MD (4436189104, bhoward@chadis.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Short Moods and Feelings Questionnaire (time frame: Day 1 well visit, day 1 + 3 months, day 1 + 6 months, and day 1 + 11.5 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in